Evaluation of Siddha herbal formulation, Vipro, in the management of uncomplicated respiratory infections
- Conditions
- Health Condition 1: J00- Acute nasopharyngitis [common cold]Health Condition 2: J029- Acute pharyngitis, unspecifiedHealth Condition 3: J069- Acute upper respiratory infection,unspecifiedHealth Condition 4: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025559
- Lead Sponsor
- Buy Happy Marketing LLP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1. Having uncomplicated respiratory infections, at least for less than 5 days, diagnosed with clinical symptoms and signs of fever, myalgia, rhinitis, sore throat, throat pain, cough, expectoration and head ache
2. Consenting to participate in the study and sign the informed consent
1. Patients with uncontrolled co-morbid conditions like Diabetes mellitus, Hypertension and Bronchial asthma
2. Patients with Lower respiratory tract infections, Chronic Bronchitis, Chronic obstructive air way problems
3. Patients with significant Cardiovascular, Neurological , Psychiatric, Gastro intestinal and other system infections or disorders and malignancies
4. Hypersensitivity to the herbal ingredients in the formulations and other medications prescribed in the study
5. Pregnant and feeding mothers
6. When the patients are interviewed for selection, all those patients who come under the testing criteria for COVID-19 as per ICMR guidelines will be tested for COVID â?? 19 and if they are found to be positive, they will be excluded from participating in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Reducing the severity of clinical symptoms such as fever, myalgia, rhinitis, sore throat, throat pain, cough, expectoration and head acheTimepoint: Daily for 7 days
- Secondary Outcome Measures
Name Time Method 1. Reducing the worsening of clinical symptoms <br/ ><br>2. Reducing the complicationsTimepoint: Daily for 7 days